If you’re deciding between photon (IMRT) and proton radiation therapy for cancer treatment, it’s important to consider both clinical evidence and practical factors. Both approaches are highly effective at targeting tumors, but they differ in how they deliver radiation. Photon therapy uses X-rays that pass through the body, while proton therapy uses charged particles that stop at depth, potentially reducing radiation exposure to nearby healthy tissues. While this can be beneficial in some cases, particularly in pediatric cancers, large clinical trials have not shown a clear advantage for proton therapy over photons in most adult cancers, and in fact has been shown to have increased risks of injury in certain circumstances. ​

​

For prostate cancer, the phase III PARTIQoL trial compared IMRT and proton therapy and found no meaningful difference in patient-reported urinary, bowel, or sexual quality of life. Cancer control rates were nearly identical at five years. Additionally, advances in photon therapy since publication of this trial—such as image-guided IMRT with focal microboost techniques—are further improving outcomes by delivering higher doses to the most aggressive parts of the tumor while minimizing damage to surrounding tissues. This photon based approach has even been shown to reduce the risk of cancer recurrence significantly in certain patients.

​

For breast cancer, evidence supporting proton therapy remains limited. While it may reduce radiation exposure to the heart or lungs in some patients, no clinical trials have demonstrated a survival or recurrence benefit over photon radiation. In fact, recent studies have highlighted potential concerns regarding increased toxicity with proton radiation. A study published in 2020 reported a 7% incidence of rib fractures among breast cancer patients treated with proton therapy, a rate much higher than typically observed with photon therapies. Given the extensive research supporting photon therapy, its broad accessibility, and growing precision with image guidance, it remains the preferred option for most patients. 

 

However, there are certain cancers where proton therapy is clearly superior—most notably in pediatric patients, where reducing radiation exposure to developing tissues is critical to minimizing long-term side effects. For adults, though, photon therapy remains the standard of care for most cancers, offering a well-established, effective, and widely available treatment option. If you’re weighing your choices, consulting with a radiation oncologist can help determine the best approach based on your specific diagnosis and needs. Our doctors at Wellspring Oncology are experts in cutting edge photon radiation techniques and also trained in utilizing Proton therapy and are able to refer appropriate patients for proton therapy in cases where it would be beneficial.